J2062 HCPCS code: Loxapine for inhalation, 1 mg
J2062 is the HCPCS Level II code for loxapine for inhalation, 1 mg. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 10 per day on outpatient hospital claims.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2019-01-01 |
| Last action effective | 2024-01-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 10 | Prescribing Information |
| practitioner claims | 10 | Prescribing Information |
What changed for J2062
- 2019-01-01: J2062 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2062?
J2062 is the HCPCS Level II code for loxapine for inhalation, 1 mg. Short descriptor: "Loxapine for inhalation 1 mg".
Does Medicare cover J2062?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2062 can be billed per day?
10 on outpatient hospital claims; 10 on practitioner claims (NCCI medically unlikely edits).
Related J20 codes
- J2001 — Injection, lidocaine hcl for intravenous infusion, 10 mg
- J2002 — Injection, lidocaine hcl in 5% dextrose, 1 mg
- J2003 — Injection, lidocaine hydrochloride, 1 mg
- J2004 — Injection, lidocaine hcl with epinephrine, 1 mg
- J2010 — Injection, lincomycin hcl, up to 300 mg
- J2020 — Injection, linezolid, 200 mg
- J2021 — Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
- J2060 — Injection, lorazepam, 2 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2062
- Watch J2062 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2062
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.